To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment - adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures - was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6-13.9).
|Original language||English (US)|
|Number of pages||4|
|Journal||Clinical Infectious Diseases|
|State||Published - 2001|
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases